Ernexa Therapeutics Inc. (ERNA) stock
ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
$1.62−0.01 (-0.61%)
Close on Nov 18, 2026Market cap $2.64MP/E –Yield –
Ernexa Therapeutics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Ernexa Therapeutics's gross profit for the twelve months ending Dec 31, 2024 was $486.00K. For fiscal 2024 it was $486.00K.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $486.00K | – |
| FY2023 | Dec 31, 2023 | -$168.00K | – |
| FY2022 | Dec 31, 2022 | $0 | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $1.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $547.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$48.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$49.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$69.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | – |
| Q1 FY2023 | Mar 31, 2023 | -$50.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | – |
See a number that looks wrong?